Eucrates Biomedical Acquisition Corp
EUCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$47.26M
Close$
Share Statistics
| Market cap | $47.26 Million |
|---|---|
| Enterprise Value | $47.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.86 |
| Beta | -0.07 |
| Outstanding Shares | 2,979,000 |
Return
| Return on Equity | 63.76% |
|---|---|
| Return on Assets | 43.59% |
| Return on Invested Capital | -5.62% |
Valuation & Multiples
| P/E Ratio | 5.4 |
|---|---|
| PEG | -6.66 |
| Price to Sales | - |
| Price to Book Ratio | 5.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -67.71 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Eucrates Biomedical Acquisition Corp
4 employeesEucrates Biomedical Acquisition Corp. is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or mo...